C‐reactive protein can be used to predict the therapeutic effects of nivolumab in patients with metastatic renal cell carcinoma
2019 ◽
Vol 26
(11)
◽
pp. 1076-1077
◽
2006 ◽
Vol 47
(10)
◽
pp. 1059
◽
2011 ◽
Vol 29
(6)
◽
pp. e133-e134
◽
2008 ◽
Vol 179
(4S)
◽
pp. 167-168
◽